A
Agilent Technologies Inc
NYSE: A · HEALTHCARE · DIAGNOSTICS & RESEARCH
$111.30
-3.11% today
Updated 2026-04-29
Market cap
$31.45B
P/E ratio
24.57
P/S ratio
4.45x
EPS (TTM)
$4.53
Dividend yield
0.87%
52W range
$104 – $160
Volume
2.3M
Agilent Technologies Inc (A) Financial statements
SEC filings — annual and quarterly data.
Profit margin
18.30%
Operating margin
22.90%
ROE
20.00%
ROA
8.53%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $4.97B | $3.31B | 53.45% | 9.33% | 66.50% |
| 2007 | $5.42B | $638.00M | 54.78% | 10.77% | 11.77% |
| 2008 | $5.77B | $693.00M | 55.35% | 13.77% | 12.00% |
| 2009 | $4.48B | $-31.00M | 51.15% | 1.05% | -0.69% |
| 2010 | $5.44B | $684.00M | 53.82% | 10.40% | 12.56% |
| 2011 | $6.62B | $1.01B | 53.35% | 16.19% | 15.30% |
| 2012 | $6.86B | $1.15B | 52.55% | 16.32% | 16.81% |
| 2013 | $3.89B | $724.00M | 48.97% | 9.91% | 18.59% |
| 2014 | $4.05B | $549.00M | 48.81% | 10.35% | 13.56% |
| 2015 | $4.04B | $401.00M | 50.54% | 12.93% | 9.93% |
| 2016 | $4.20B | $460.00M | 52.28% | 14.64% | 10.95% |
| 2017 | $4.47B | $684.00M | 53.87% | 18.81% | 15.30% |
| 2018 | $4.91B | $316.00M | 54.68% | 18.40% | 6.43% |
| 2019 | $5.16B | $1.07B | 54.33% | 18.23% | 20.74% |
| 2020 | $5.34B | $719.00M | 53.14% | 15.85% | 13.47% |
| 2021 | $6.32B | $1.21B | 53.92% | 21.32% | 19.15% |
| 2022 | $6.85B | $1.25B | 54.35% | 23.63% | 18.31% |
| 2023 | $6.83B | $1.24B | 50.71% | 19.76% | 18.15% |
| 2024 | $6.51B | $1.29B | 54.30% | 22.86% | 19.80% |
| 2025 | $6.95B | $1.30B | 52.43% | 21.29% | 18.75% |